key: cord-0036446-bhlsxrdj
authors: Chen, Feng; Zhao, Dawei; Wen, Shuo; Wang, Wei
title: Influenza
date: 2015-04-30
journal: Radiology of Infectious Diseases: Volume 1
DOI: 10.1007/978-94-017-9882-2_21
sha: 78653f1c980087c61fad5bf9d4e7acbfa1d8da03
doc_id: 36446
cord_uid: bhlsxrdj

Influenza, briefly known as flu, is an acute respiratory infectious disease caused by influenza virus. It spreads via droplets, with strong infectivity. Its incident rate ranks first in legal infectious diseases, with occurrences of outbreaks or pandemics. Its clinical symptoms are characterized by acute onset of high fever, fatigue, systemic muscular soreness and pain, as well as mild respiratory tract symptoms. Influenza more commonly occurs in autumns and winters. Although it has a short disease course and is self-limited, it may be complicated by pneumonia and other serious complications in populations including the elderly, infants and young children, patients with cardiac or pulmonary diseases, patients with other chronic diseases, and patients with compromised immunity. In some serious cases, death may even occur.

In the year 1971, the WTO offi cially claimed the nomination system of infl uenza virus. Based on the antigenic difference of the virus nucleocapsid protein (NP), infl uenza viruses are classifi ed into types A, B, and C (Table 21 .1 ). Infl uenza virus is an RNA virus, which is most stable in an environment with a pH value of 6.5-7.9 and has weak resistance to heat. It loses its pathogenicity at a temperature of 56 °C for several minutes and is inactivated at a temperature of 100 °C for 1 min. Infl uenza virus is more stable in an environment of low temperature. It can survive for more than 1 month at 4 °C and for more than 5 months at −70 °C. Infl uenza virus is sensitive to dryness, ultraviolet radiation, ethanol, iodine, and other common disinfectants. Rapid mutation and evolution are its main features, which is the result of antigenic structural changes in hemagglutinin and neuraminidase, particularly hemagglutinin. Each variation of hemagglutinin and neuraminidase continually combines to form new mutant strains, and a new strain may defeat the established immunity against the former strain. Only when the population immunity is compromised to a certain level can the new strain likely invade the susceptible populations to cause an outbreak. This is the main reason for recurrent pandemics of infl uenza. Signifi cant variation commonly occurs in infl uenza A virus, but rarely in infl uenza B virus and none in infl uenza C virus.

Infl uenza caused by H1N1 subtype, H2N2 subtype, H3N2 subtype of infl uenza A virus, and infl uenza B virus and infl uenza C virus is known as classical infl uenza. Apart from these viruses, infl uenza caused by other infl uenza viruses is known as a newly emerging infl uenza.

As early as in the years of 412 BC, Hippocrates described a fl u-like disease. But the fi rst detailed description of infl uenza pandemic was in 1580. A total of 31 infl uenza pandemics have been recorded in documents, indicating periodic occurrence of infl uenza pandemics. Since the twentieth century, four global infl uenza pandemics have been recorded, respectively, in 1918, 1957, 1968, and 1977 , all of which were caused by strains of infl uenza A virus.

Patients with infl uenza and asymptomatic infected patients are the main sources of infection, whose infectivity lasts from the end of incubation period to the acute stage after onset. In the fi rst 2-3 days after the onset, their infectivity is the strongest. When adults and elder children are sustaining seasonal infl uenza with no complications, virus excretion persists for 3-6 days in the respiratory secretions. Hospitalized adult patients can disseminate the viruses with pathogenicity for 1 week or longer after the onset. Studies have demonstrated that in infants and young children with infl uenza or human patients with infl uenza caused by avian H5N1 subtype of infl uenza A virus, long-term virus excretion is common, usually persisting for 1-3 weeks. In addition, patients with immunodefi ciency such as patients with AIDS may also show a prolonged period of virus excretion.

Infl uenza mainly spreads via droplets in the air. The infl uenza virus exists in the respiratory secretions of symptomatic and asymptomatic patients. By talking, coughing, and sneezing, droplets or aerosols carrying the virus are disseminated into the air. The inhalation of the droplets or aerosols by a susceptible person can cause the infection. The virus can also spread via direct or indirect contact to mucosa of the mouth, nasal cavity, and eyes. Therefore, infl uenza has a strong infectivity, with rapid spreading and extensive prevalence. Its spreading speed is related to the population density.

Populations are generally susceptible and the susceptibility is not related to gender and occupation. Once cured, certain immunity can be acquired. The antibody can be fi rstly detected in 1 week after the infection, which peaks at weeks 2-3 after the infection and begins to decrease in 1-2 months. The antibody can be detected in the blood and secretions of nasal mucosa. No cross-immunity exists among infl uenza A, B, and C and among subtypes of infl uenza A. Infl uenza has a repeated onset and the acquired immunity after the infection only persists for a short period of time. Although antibody exists in the blood, the person can be reinfected by the same virus. The infl uenza virus is always subject to variance, and the highest incidence rate is found in the populations of young adults and adolescents.

After infection of infl uenza virus, the following populations are likely to develop into serious cases. Therefore, focused attention should be paid on such patients. Infl uenza virus-related tests and examinations should be performed as early as possible to effectively treat such patients. These populations include (1) women during pregnancy; (2) infl uenza patients with accompanying diseases or conditions as follows: chronic respiratory disease, cardiovascular disease (with hypertension excluded), hepatic or renal disease, blood disorder, neurological disease, neuromuscular disease, metabolic and endocrine diseases, immune suppression (including HIV infection and use of immunosuppressant), being attended in healthcare institutions, and long-term medication of aspirin under the age of 19 years; (3) obese population with a BMI above 30; (4) children under the age of 5 years (those under the age of 2 years are more likely to suffer from complications); and (5) the elderly above the age of 65 years.

Infl uenza occurs all year round. In the northern area of China, its incidence commonly peaks in winters and springs, while in the southern area of China, its incidence commonly peaks in summers and winters. Infl uenza A commonly occurs to cause outbreaks or even pandemics, with occurrence of a small-scale epidemic every 2-3 years. Based on the four pandemics of infl uenza, infl uenza A is likely to occur in pandemic every 10-15 years. Infl uenza B commonly occurs in outbreaks or small-scale epidemics and infl uenza C occurs sporadically. Infl uenza has a sudden onset and spreads rapidly. Its spreading peaks within 2-3 weeks and spontaneously terminates after 3-4 weeks. Its incidence rate is high but mortality rate is low. Its spreading is usually along the transportation lines, generally from urban to rural and from densely populated working places to scarcely populated resident communities. 

Infl uenza virus causes damages to cells and cell atrophy via virus replication, with consequent occurrence of infl uenza. The loss of important cellular protein may lead to death of cells. The epithelial cells of the infected mucosa wrinkle and fold, with karyopyknosis, cilia loss, and shedding of mucosal columnar epithelium after infection. In addition to the directly induced cellular death, infl uenza A and B viruses can induce apoptosis of infected cells. The mechanism underlying the apoptosis of infected cells induced by infl uenza viruses remains elusive, which is possibly related to Fas abnormality during virus replication.

After the initial infection, lesions may involve the trachea, bronchi, and lower respiratory tract. In the cases of simplex acute infl uenza, extensive infl ammatory changes, mucosal lesions, and edema occur in the larynx, trachea, and bronchi. Biopsy demonstrates vacuolar degeneration of bronchial mucosa columnar epithelial cells, loss of cells, and even extensive shedding which involves basilar cells, shedding of ciliated cells, and metaplasia of epithelial cells. Antigen of infl uenza virus can be detected in surface layer of epithelial cells. There are congestion and edema of lamina propria mucosa cells with accompanying infi ltrations of lymphocytes and monocytes that persist for more than 2-3 days. Subsequently, the undifferentiated basilar cells regenerate. With the conditions improved, the layer of epithelial cells can recover through rapid regeneration and metaplasia.

In fatal infl uenza-related viral pneumonia, the gross pathological changes include bleeding, severe tracheobronchitis, and pneumonia. The lesions are characterized by extensive bronchial and bronchiolar cell necrosis, with accompanying shedding of ciliated epithelial cells, fi brin exudation, infl ammatory cell infi ltration, hyaline membrane formation, congestion of alveolar and bronchial epithelial cells, interstitial edema, and mononuclear cell infi ltration. The later changes also include diffuse alveolar damage, lymphocytic alveolitis, metaplastic regeneration of epithelial cells, or even extensive fi brosis of lung tissues. By autopsy, extensive necrotic tracheobronchitis can be found, with accompanying ulceration and tracheal mucosal shedding and necrosis. Above 1/3 of the cases have diffuse brain tissue hyperemia and edema, myocardial cell swelling, interstitial hemorrhage, lymphocytic infi ltration, necrosis, and other infl ammations.

The incubation period commonly lasts for 13 days and sometimes only for several hours. Its onset is sudden and acute, with mainly systemic toxic symptoms. The respiratory tract symptoms are slight or not obvious. According to the clinical manifestations, infl uenza can be divided into the following types:

It is the most commonly found infl uenza, with sudden onset and symptoms of aversion to cold and high fever. The body temperature can be up to 39-40 °C. Fever is the most important initial symptom, commonly with accompanying headache, systemic muscular and joint soreness and pain, fatigue, poor appetite, and other toxic symptoms, whose severity is related to the degree of fever. Commonly, fever in patients with infl uenza is persistently high, typically for 3 days. Some patients may experience photophobia and lacrimation. And other symptoms including nasal obstruction, runny nose, sore throat, coarse voice, and other respiratory tract symptoms can be found at the onset. After the body temperature returns to normal, the systemic symptoms are improved, but with increasingly obvious respiratory symptoms. Coughing and physical strength commonly require 1-2 weeks to return back to normal. By physical examination in the acute stage, the patients have an acute complexion, with fl ushing on the face, mild conjunctival congestion, as well as damp and warm skin. In some patients with pharyngeal congestion, oral mucosal herpes may occur.

Pneumonic infl uenza can be either primary or secondary to simplex infl uenza. The occurrence of pneumonic infl uenza is the result of infl uenza virus infection spreading from the upper respiratory tract downward to the lower respiratory tract, which is more common in the elderly, children, patients with primary cardiopulmonary disease (especially rheumatic heart disease and left atrioventricular valvular stenosis), women in pregnancy, and populations with immunodeficiency. But in up to half of the cases, no underlying disease is reported. The manifestations of typical pneumonic infl uenza include high fever that persists for a long period of time, rapid occurrence of dyspnea, cyanosis, severe cough, foamy thick sputum or purulent sputum, and bloody sputum. By physical examination, breathing sounds of both lungs are low, with moist rales. Generally, the course of the disease lasts for 3-4 weeks. Antibacterial therapies have no therapeutic effi cacy. Death may occur due to heart failure or respiratory and circulatory failure and pneumonic infl uenza has a high mortality rate.

Toxic infl uenza is extremely rare, which is caused by invasion of infl uenza virus into the central nervous system and cardiovascular system, with manifestations of toxic symptoms. Clinically, the symptoms are characterized by encephalitis or meningitis, including high fever, coma, delirium, and convulsion. Some serious symptoms may be found such as cerebral meningeal irritation and disseminated intravascular coagulation. Toxic infl uenza has a high mortality rate.

Gastrointestinal infl uenza is common in children, with typical symptoms of nausea, vomiting, diarrhea, and abdominal pain. Generally, it can be cured within 2-3 days.

Infl uenza prevailing in different populations is characterized by different clinical manifestations. The main manifestations of infl uenza in special populations are described as the following:

During the fl u-prevailing seasons, more than 40 % of preschoolers and 30 % of school-aged children sustain infl uenza. Infl uenza in common healthy children is mild, with symptoms of fever, cough, runny nose, nasal obstruction, sore throat, and headache. In some rare cases, muscular pain, vomiting, and diarrhea occur. Infl uenza in infants and young children commonly has atypical clinical symptoms, with possible occurrence of high fever and convulsion. Neonatal infl uenza is rare but its occurrence is commonly complicated by pneumonia. In addition, neonatal infl uenza commonly has septicemic manifestations including drowsiness, feeding refusal, and apnea. In young children, infl uenza-induced laryngitis, tracheitis, bronchitis, bronchiolitis, pneumonia, and gastrointestinal symptoms are more common than in adults.

The elderly infl uenza refers to infection of infl uenza by elderly population aged above 65 years. Because this population commonly has primary respiratory or cardiovascular disease, the conditions of the elderly infl uenza are commonly serious, with rapid development. The possibility of pneumonia in the elderly patients with infl uenza is higher than that in the adult patients with infl uenza. In this population, infl uenza may involve other systems to cause infl uenza-related viral myocarditis and infl uenza-related viral encephalitis.

In addition to fever and cough, women infected by infl uenza virus in middle and late stages of pregnancy are susceptible to pneumonia. The conditions rapidly progress into dyspnea, hypoxemia, and even acute respiratory distress syndrome (ARDS). Subsequently, miscarriage, premature birth, intrauterine fetal distress, and death may occur. Infection of infl uenza in middle and late stages of pregnancy can induce aggravation of the basic disease. In some serious cases, death may occur in 2 days after the onset; antiviral therapy should be administered. Otherwise, delayed treatment obviously increases the mortality rate.

Immunodefi cient individuals, such as recipients of organ transplantation, patients with HIV/AIDS, and long-term users of immunosuppressants, are at a signifi cantly higher risk of severe infl uenza once infected. They are predisposed to infl uenza-related viral pneumonia and may experience rapid onset of fever, cough, dyspnea, and cyanosis, with a high mortality rate.

The incidence rate of bacterial pneumonia in patients with infl uenza has been reported to be 5-15 %. Its common pathogens include Streptococcus pneumoniae and Staphylococcus aureus , especially methicillin-resistant Staphylococcus aureus (MRSA). The susceptible populations include the elderly and individuals with chronic pulmonary disease or heart disease.

Other pathogenic organisms inducing pneumonia in patients with infl uenza include chlamydia, mycoplasma, Legionella pneumophila , and fungi ( Aspergillus ). When infl uenza complicated by pneumonia is ineffectively treated by routine anti-infective therapies, it is likely to be caused by these pathogens.

It is a disease of the liver and central nervous system complicating infl uenza A and B. And Reye syndrome also occurs in patients with herpes zoster virus infection. Reye syndrome is commonly found in children under the age of 14 years, especially those using aspirin or other analgesic and antipyretic agents containing salicylic acid. Reye syndrome is rarely found in adult patients with infl uenza.

Other complications include myositis that commonly occurs in children and rarely occurring myoglobinuria and renal failure, myocardial lesions, encephalitis, and meningitis. Myositis is characterized by pain and tenderness of the gastrocnemius and soleus muscle, possible convulsion of lower limbs, and even inability in walking in serious cases. Myositis more commonly complicates infl uenza B, with a temporary increase in serum creatine phosphokinase level that generally returns to normal in 3-4 days.

By routine blood test in the acute stage, peripheral WBC count decreases, lymphocyte count relatively increases, and there is possible absence of eosinophils. In cases with infl uenza complicated by bacterial infection, WBC count increases with increased percentage of neutrophils.

Mucosal epithelial cells from the nasopharynx of the patients are collected for smear. It can detect necrosis of columnar ciliated epithelial cell necrosis and eosinophilic inclusion bodies in the cytoplasm. Immunofl uorescence or enzyme-labeled staining can be applied to detect the viral antigen in the exfoliative cells, with high sensitivity. Monoclonal antibody can be applied to distinguish infl uenza A, B, and C.

Double sera are collected at the acute stage and at weeks 3-4 after onset are collected for hemagglutination inhibition test, enzyme-linked immunosorbent assay, and complement fi xation test to detect antibody of infl uenza virus. An increase in titer by above four times has diagnostic signifi cance, with a positive rate of 60-80 %.

By using PCR technique, infl uenza virus genes can be detected directly from respiratory specimens of the patients, which is more sensitive and rapid than virus culture.

Isolation of virus is the golden standard for the diagnosis of infl uenza.

X-ray is the most commonly applied examination for the diagnosis of pneumonic infl uenza or secondary bacterial pneumonia.

CT scanning is a commonly applied facilitative examination to demonstrate intrapulmonary lesions that fail to be demonstrated by X-ray.

Imaging demonstrations show the severity of the disease, and high-risk populations are the focus of imaging examinations. In addition, imaging demonstrations of intrapulmonary basic disease should be paid focused attention for differentiation.

Chest X-ray demonstrations mainly include interstitial pneumonia and bronchial pneumonia, with early demonstrations of enhanced lung markings with blurry boundaries that are more obvious in both lower lungs and increased density in ground-glass opacities. Due to not obvious clinical symptoms, the diagnosis cannot be hardly defi ned. With progress of the conditions, the X-ray demonstrations are reticular shadow and reticulonodular shadow in the long fi elds with nodules being smaller than 5 mm, which can be concurrent with enhanced blurry lung markings. The lesions are commonly distributed in lower fi elds of both lungs and around the hilum (Figs. 21.1 and 21.2 ) . The pathological changes include exudative infl ammation at the alveolar wall and lobular septum. In the late stage, due to infl ammatory obstruction of bronchioles, cystic changes occur in different sizes, with demonstrations of a honey-comb-like lung, shrinkage of lung volume, elevated diaphragm, and shifted interlobar fi ssures. By lung biopsy, about 30 % of the cases can be confi rmed with pulmonary interstitial fi brosis but no abnormalities by chest X-ray. X-ray is not suffi ciently sensitive to alveolitis and the demonstrations are nonspecifi c.

A boy aged 7 years complained of fever for 4 days with a body temperature of 39.1 °C. Laboratory tests show a WBC of 4.1 × 10 9 /L, LY% of 62.l %, and GR% of 26.6 %. 

Compared to traditional chest X-ray, CT scanning can more favorably demonstrate the conditions. It facilitates more accurate assessment about the severity, range, and location of the lesions. By adjusting the window width and window level, subtle dynamic changes and distribution of lesions can be demonstrated, providing more information than chest X-ray. CT scanning demonstrations include large fl ake of consolidation opacity in the lung lobe or segment with accompanying air bronchogram, small nodular shadows, ground-glass opacity, tree-in-bud sign, and mosaic perfusion as well as thickened interlobular septum, pleural inferior line, thickened adjacent pleura, and pleural effusion.

Bacterial pneumonia is characterized by alveolar pneumonia (lobar pneumonia) and bronchopneumonia (lobular pneumonia). The manifestations of alveolar pneumonia include alveolar consolidation, which can be found in the cases of pneumococcus infection, pneumobacillus infection, and legionella infection. The lesions involve singular or multiple lung lobes. Chest X-ray demonstrates lobar or partial lobe occupied consolidation opacity with high even density with internal bronchial shadow containing air. The lesions at different locations have different radiological demonstrations. The intrapulmonary lesions are mostly absorbed within 2 weeks. In addition to the abovementioned pathogenic bacterial infections, bronchial pneumonia can also be caused by Haemophilus infl uenzae , Staphylococcus aureus , and Gramnegative bacillus. Bronchial pneumonia commonly occurs in infants and young children, the elderly, and extremely weak patients. Chest X-ray demonstrates enhanced and thickened pulmonary markings, blurry nodular shadows in diameters of 6-8 mm, or blurry fl akes of shadows in diameters of 10-25 mm. And relatively larger patches of uneven shadows with poorly defi ned boundaries are the result of overlapped multiple lobular alveolitic shadows (Fig. 21.3 ) . Bronchial blockage by mucus can be demonstrated as lobular atelectasis or focal emphysema in the lesion area. Bronchial blockage can result in a small triangular atelectasis. The lesions are mostly located in the medial zone of both lower lungs, with more posterior lobar lesions than anterior lobar lesions. They are distributed along the bronchial branches, with unobstructed bronchi in the pulmonary segment and lobe. Congestion, edema, and infl ammatory exudates of the terminal bronchial mucosa can cause obstructive emphysema, with manifestations of increased transparency of both lung fi elds, expanded thorax, widened intercostal space, and fl at low diaphragm.

A female patient aged 45 years complained of cough for 7 days and fever for 3 days, with a body temperature of 38.4 °C. Laboratory tests show a WBC of 11.25 × 10 9 /L, PCO 2 of 35.5 mmHg, and PO 2 of 76 mmHg. 

Chest CT scanning is commonly applied for early diagnosis, lesion assessment, and differential diagnosis. The demonstrations are characterized by consolidation opacities with morphologically consistent distribution with lung lobes, air bronchogram, and nodular shadow and patches of shadows with different sizes and blurry boundaries along with bronchial bundles as well as possible occurrence of lobular atelectasis or focal emphysema (Figs. 21.4 and 21.5 ) .

A boy aged 15 years complained of fever for 3 days, with a body temperature of 39.2 °C. Laboratory tests show a WBC of 11.1 × 10 9 /L and GR% of 86 %. 

Infants and young children as well as preschoolers are highrisk populations of infl uenza. Generally, healthy children infected by infl uenza virus may have slight symptoms. Neonatal infl uenza is rarely found, but is commonly complicated by pneumonia (Figs. 21.5 and 21.6 ).

A boy aged 1 year complained of fever for 3 days and drowsiness. 

A boy aged 12 years complained of cough for 14 days and fever for 3 days, with a body temperature of 39.8 °C. Laboratory tests show a WBC of 3.8 × 10 9 /L, pH of 7.513, PCO 2 of 34.9 mmHg, and PO 2 of 77.9 mmHg. Fig. 21 .6 Infl uenza complicated by pneumonia. Chest X-ray demonstrates thickened pulmonary markings in both lungs, decreased transparency of the right lung fi eld, and fl akes of blurry shadows along the pulmonary markings in the right lung, with fusion of some shadows in consolidation opacity

Due to relatively weak immunity of the elderly and common occurrence of basic disease in this population, the conditions are commonly serious after infection of infl uenza virus, with rapid progress and a high incidence rate of pneumonia. Infl uenza complicated by pneumonia in the elderly is likely to develop into severe pneumonia, with possible occurrence of death (Fig. 21.7 ) .

A male patient aged 70 years complained of fever for 5 days, with cough, fatigue, and a body temperature of 38 °C. Laboratory tests show a WBC of 3.5 × 10 9 /L and SaO 2 of 89 %. 

Women in the middle and late stage of pregnancy with infection of infl uenza virus are susceptible to pneumonia with possible occurrence of acute respiratory distress syndrome (ARDS) and even death (Fig. 21.8 ) .

Individuals with immunodefi ciency are more likely to sustain serious infl uenza after their infection of infl uenza virus. In addition, multiple complications tend to occur (Fig. 21.9 ).

During the prevailing period of infl uenza, its diagnosis presents no challenge, which can be made based on clinical symptoms and stratifi ed diagnosis. However, early sporadic cases should be diagnosed comprehensively based on the epidemiological history, clinical manifestations, and laboratory fi ndings. The diagnostic basis includes history of contact to infl uenza, typical symptoms and physical signs, and pathogen detection. Successful detection of infl uenza virus or virus antigen or serious antibody from nasal or pharyngeal secretions can defi ne the diagnosis.

During the prevailing period of infl uenza, the occurrence of (1) fever with cough and/or sore throat and other acute respiratory symptoms;

(2) fever with acute aggravation of underlying chronic lung disease; (3) fever in infants and young children, with no other symptoms and signs; (4) newly onset respiratory symptoms or aggravation of underlying respiratory symptoms in the elderly above the age of 65 years, with or without fever; and (5) fever or low body temperature in seriously ill patients should be suspected as the cases of infl uenza. In any other periods, the occurrence of fever with cough and/or sore throat and other acute respiratory symptoms should be suspected as the cases of infl uenza after an epidemiological history related to infl uenza is reported. The epidemiological history may be a visit to the area or community with outbreak of infl uenza within 7 days before the onset, living together or having close contacts to suspected cases of infl uenza, and traveling back from the country or area with prevailing infl uenza.

The cases with clinical manifestations and that are positive in at least one of the following pathogen detections can be defi ned as infl uenza: (1) nucleic acid detection of infl uenza virus, (2) rapid antigen detection of infl uenza virus which should be combined with epidemiological history, (3) isolation and culture of infl uenza virus, and (4) specifi c IgG antibody of infl uenza virus in double sera from acute stage and convalescence stage showing an increase of above four times.

Radiological fi ndings demonstrate the severity of the conditions in a certain degree. In slight cases, chest radiology demonstrates no obvious abnormalities or only thickened pulmonary markings and blurry interstitial pneumonia. In serious cases complicated by pneumonia, intrapulmonary consolidation changes can be found in a large range. The lesions may be distributed consistently with morphology of pulmonary lobe or segment. In some cases, the complications of emphysema and acute respiratory distress syndrome occur, with multiple diffusive lesions in both lungs that rapidly changes. In rare cases, life can be threatened.

A female patient aged 22 years had been pregnant for 39 weeks and complained of cough for 7 days and fever for 4 days, with a body temperature of 39.5 °C. Laboratory tests show a WBC of 14.3 × 10 9 /L and SaO 2 of 85 %. 

It is also known as acute rhinitis or upper respiratory catarrhal infl ammation. 

Other viral pneumonias include respiratory syncytial virus pneumonia, adenovirus pneumonia, and measles virus pneumonia, with imaging demonstrations of intrapulmonary ground-glass opacity.

The X-ray demonstrated morphology of adenovirus pneumonia lesions is closely related to the severity and stage of the disease. The early demonstrations include thickened

A male patient aged 35 years had a case history of positive HIV antibody and complained of fever for 4 days, with chest pain, fatigue, and a body temperature of 38.7 °C. Laboratory tests show a WBC of 10 × 10 9 /L, GR% of 85 %, and SaO 2 of 86 %. 

Respiratory syncytial virus is the most common pathogen that causes infantile viral pneumonia. The typically change is diffusive interstitial infi ltration. Most of the cases have small fl akes of shadows that are commonly found in 2-3 lung lobes. About 1/3 of the patients experience emphysema or excessive gases in the lung of different severities. About 15 % of the cases have only X-ray demonstration of excessive gas in the lungs. About 1/4 of the cases have pulmonary consolidation or atelectasis, with the lesions confi ned inferior to the pulmonary segments and commonly found in the right upper lung lobe. Imaging demonstration of absorption of pulmonary consolidation obviously lags behind the actual improvement of the symptoms and signs.

Measles virus pneumonia is more common in infants, young children, and individuals with compromised immunity and commonly occurs in the early period of the disease. Chest X-ray demonstrations are mainly fl akes or diffusive ground-glass opacity and/or thickened bronchial vascular bundles. CT scanning demonstrates lobular central nodules with poorly defi ned boundaries, ground-glass opacity, thickened lobular septum, and consolidation shadows in lobules or segments.

Mycoplasma pneumonia is an acute respiratory tract infection with accompanying pneumonia caused by mycoplasma. It occurs in both children and adults, with positive cold agglutination test. Chest X-ray demonstrates early lesions of only increased pulmonary markings with poorly defi ned boundaries. The lesions then develop into blurry cloudy or homogeneous shadows that commonly distribute in the middle and lower lung fi elds. The shadows close to the hilum are denser with gradually lighter shadows towards the periphery and poorly defi ned boundaries. The lesions commonly have no involvement of the whole lobe. Mycoplasma pneumonia with lobar lesions cannot be differentiated from lobar pneumonias caused by other pathogens. CT scanning demonstrations are mainly pulmonary ground-glass opacity and nodular shadow or small patches of consolidation shadows of air cavities that is the characteristic CT scanning demonstration, thickened bronchial vascular bundles, tree-in-bud sign, large fl akes of consolidation shadows and possibly accompanying mediastinal lymphadenectasis, and pleural effusion. The pulmonary lesions are usually absorbed in 2 weeks or even in 4-6 weeks.

Allergic pneumonia is a group of non-asthmatic allergic lung disease caused by different allergens. Chest X-ray may demonstrate normality or diffusive interstitial fi brosis. The commonly demonstrated lesions include bilateral patches or nodular infi ltration, thickened bronchial lung markings, or small acinus-like changes. Hilar lymphadenectasis and pleural effusion are rare. CT scanning demonstrates thickened bronchial vascular bundles, small patches of shadows along bronchial vascular bundles with poorly defi ned boundaries, and ground-glass opacity. CT scanning demonstrations are not regular. The severity of lesions by radiology may be inconsistent with the clinical symptoms. 

Klebsiella pneumonia is an acute pulmonary infl ammation caused by Klebsiella . It is more common in individuals with chronic alcoholism, individuals with malnutrition, and the elderly. Chest X-ray demonstrations can be divided into three types: (1) increased lung markings, (2) lobular or diffuse pneumonia, and (3) lobar consolidation or pulmonary abscess. CT scanning can more favorably demonstrate the lesions than chest X-ray. The early consolidations in the cases of Klebsiella pneumonia have lobular distributions, with patches or irregular dense shadows that scatter and commonly involve multiple pulmonary segments. The lesions rapidly fuse to lobar consolidation that is more common in the right upper lobe. Due to thick and heavy exudate fl uid in the lesions, the interlobar space drops. Necrosis of the lesions induces pulmonary abscesses, which are multiple small cavities with a diameter of less than 2 cm. The healing is slow, commonly with residual extensive fi brosis.

Acute respiratory distress syndrome (ARDS) is an acute respiratory failure syndrome caused by extrapulmonary and intrapulmonary serious diseases. The lesions are basically diffusive damages to pulmonary capillaries with increased permeability. The pathological changes mainly include pulmonary emphysema, formation of hyaline membrane, and pulmonary atelectasis. And clinically it is characterized by progressive respiratory distress and intractable hypoxemia, which are typical manifestations of acute pulmonary lesions in the advanced stage. The radiological demonstrations of ARDS are related to leakage of edema fl uid containing a large quantity of proteins to fi ll in the alveolar cavity because of damaged alveolar epithelial cells or diffusively destructed alveolar walls. Chest X-ray commonly demonstrates diffusively distributed shadows in both lungs and characteristic radiological changes of basic diseases such as severe pneumonia caused by various pathogens. CT scanning demonstrates unevenly distributed lesions, including (1) normal or nearly normal gravity-independent area (mainly the anterior chest in supine position), (2) ground-glass opacity at the anterior and middle regions, and (3) consolidation shadow in the gravity-dependent area. In the cases with no lesions in the pulmonary capillary membrane, the patches of shadows in both lungs are evenly distributed, with no gravity dependency and no gravity-dependent change after changing body posture, which facilitates the differentiation from pulmonary infectious diseases. The advanced manifestations of ARDS include twisted bronchi and traction of bronchi and shrinkage of pulmonary segment or lobe volume, with grid-like shadow, cord-like shadow, and honeycomb-like shadow. In serious cases, honeycomb-like lung occurs.

Adamantane resistance among infl uenza A viruses isolated early during the 2005-2006 infl uenza season in the United States

Application of computed tomography in childhood respiratory infections

Emerging infl uenza

Modifying clinical practices to manage infl uenza in children effectively

Viral pneumonias in adults: radiologic and pathologic fi ndings

Medical management of infl uenza infection

Complications of viral infl uenza

A (H5N1) virus attachment to lower respiratory tract

Clinical, radiological and pathological diagnosis of non-specifi c interstitial pneumonia

Retrospective analysis of 653 cases of infl uenza during its prevalence

Differential expression of chemokines and their receptors in adult and neonatal macrophages infected with human or avian infl uenza viruses